Johnson & Johnson Current Deferred Revenue (Quarterly) Trends

Johnson & Johnson (JNJ)

207.56 -0.07 (-0.03%) USD | NYSE | Dec 29, 16:00

207.66 +0.10 (+0.05%) Pre-Market: 05:37

View Current Deferred Revenue (Quarterly) for JNJ.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

Amgen, Inc.	--
Gilead Sciences, Inc.	--
Eli Lilly & Co.	--
Regeneron Pharmaceuticals, Inc.	Upgrade
Protagonist Therapeutics, Inc.	Upgrade